tiprankstipranks
Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom
Company Announcements

Plus Therapeutics Secures Loan to Terminate Debt and Regain Freedom

Don't Miss our Black Friday Offers:

An update from Plus Therapeutics (PSTV) is now available.

Plus Therapeutics, Inc. recently took advantage of their established margin loan facility with Pershing LLC, borrowing $3.3 million to settle their existing debt with Oxford Finance, LLC. By repaying the Oxford Term Loan in full, the company has not only cleared the outstanding principal and interest but also terminated Oxford’s security interest in its assets and lifted various restrictions and covenants associated with the loan. This strategic financial move could signal a new phase of operational freedom for the company.

For a thorough assessment of PSTV stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyPlus Therapeutics presents updated progress from its ReSPECT-LM Phase 1 trial
TheFlyPlus Therapeutics to present FORESEE clinical trial summary
TheFlyPlus Therapeutics subsidiary to present data on CNSide CSF Assay Platform
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App